ENTITY

Cellid (299660 KS)

23
Analysis
Health CareSouth Korea
Cellid, Co., Ltd. develops biotechnology. The Company develops innovative immunotherapeutic vaccines, immunology and molecular biology technology, and other related products. Cellid also manufactures and distributes pharmaceuticals and functional foods.
more
09 Dec 2021 03:19

Short Position Approach on the Index Entrants on December 10 in Korea

The effective date for rebalancing KOSPI 200 and KOSDAQ 150 is this Friday, meaning that this is the first trading day that short selling is...

Logo
265 Views
Share
bullishSK Materials
25 Nov 2021 08:55

15 Adds & 15 Deletes in KOSDAQ 150 Rebalancing: Passive Impact & Trade Approaches

The KOSDAQ 150 December rebalancing features a total of 15 additions and 15 deletions. This post details the results as well as the passive impact...

Logo
310 Views
Share
bullishCoocon Corp
24 Nov 2021 20:11

KOSDAQ150 Index Rebalance: Pullback Done; Buy Adds & Sell Deletes

There are 15 changes for the KOSDAQ150 index in December. The impact on the deletions is larger than that on the inclusions. A long adds/short...

Logo
363 Views
Share
bullishM2N Co.,Ltd
02 Nov 2021 13:43

KOSDAQ150 Index Rebalance Preview: 15 Potential Changes and Large Turnover

At the end of the review period, we see 15 potential changes for the KOSDAQ150 index. Most of the changes are high probability. The adds could...

Logo
599 Views
Share
x